9 June 2023 - The following documents are now available: ...
11 May 2023 - Information regarding the experts in HTA to support the HTA Review is now available. ...
28 April 2023 - The Australian Government is laying the foundations for significant reforms to Medicare, with a comprehensive package of ...
26 April 2023 - The changes in sales right for Gavreto (pralsetinib), an RET inhibitor, may likely negatively influence the ...
20 April 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 24 March 2023 and ...
11 April 2023 - Medicines Australia welcomes the official start of the Health Technology Assessment (HTA) Review consultation that should ...
11 April 2023 - The first round of public consultation for the HTA Review is open. Submissions will be accepted ...
4 April 2023 - Australia’s health funding system is “fragmented and disjointed” and in critical need of being simplified, says ...
22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...
22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...
15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...
9 March 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 13 February 2023. ...
3 March 2023 - "There are 30 actions we committed to in the interim response – these are part of ...
28 February 2023 - Today marks one year since the PHARMAC Review was delivered to then Health Minister Andrew Little. ...
20 February 2023 - The Office for Life Sciences has today announced that Lord James O’Shaughnessy will conduct a review ...